Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01543672 · ClinicalTrials.gov registry record · Phase 1
Irradiation of Large Lung Tumors or Two or More Lung Metastases Simultaneously
A Phase 1 study of Lung Cancer and Metastatic Lung Cancer, sponsored by The Netherlands Cancer Institute.
- Completed
- Registry status
- Phase 1
- Development phase
- 62
- Enrollment target
- 5
- Study locations
NCT01543672: Completed Phase 1 study of Lung Cancer and Metastatic Lung Cancer, sponsored by The Netherlands Cancer Institute.
NCT01543672 is a Phase 1 study of Lung Cancer and Metastatic Lung Cancer that has completed, run by The Netherlands Cancer Institute. The registered enrollment target is 62 participants, below the 936-participant average among 409 other Lung Cancer trials with a reported enrollment target (93% lower). The trial reports 5 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01543672, a Phase 1 study of Lung Cancer and Metastatic Lung Cancer, has completed, sponsored by The Netherlands Cancer Institute.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 62 participants
- Enrollment target
- 5
- Study locations
Study Summary
Treatment of larger tumor volumes or ≥ 2 lung metastases simultaneously in lung cancer patient using Stereotactic Body Radiation Therapy (SBRT) in a mean-lung dose escalation study.
Primary Outcome
The assessment of the maximum mean lung dose that can be safely treated with SBRT and that is associated with a 20% probability of the DLT.
Conditions Studied
Interventions
- RADIATION Stereotactic Body Radiotherapy (SBRT)
Study Locations (5)
Michigan
- Beaumont Hospital, Royal Oak - Royal Oak
Pennsylvania
- Thomas Jefferson University/ Kimmel Cancer Center - Philadelphia
Ontario
- Prinses Margaret Hospital - Toronto
Bavaria
- Universitätsklinikum Würzburg - Würzburg
Other
- NKI-AVL - Amsterdam
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2011-11-22 |
| Est. Completion | 2017-10-31 |
| Phase | Phase 1 |
What the finished NCT01543672 record still lists
NCT01543672 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 62 participants, a relatively small participant target, below the 936-participant average among 409 other Lung Cancer trials with a reported enrollment target (93% lower).
The record links to 2 conditions, with Lung Cancer appearing as the primary indexed condition, and to 1 intervention - of which Stereotactic Body Radiotherapy (SBRT) is the first listed.
NCT01543672 lists 5 locations in 5 states (Michigan, Pennsylvania, Ontario).
Frequently Asked Questions
What is clinical trial NCT01543672 about?
NCT01543672 is a clinical study titled "Irradiation of Large Lung Tumors or Two or More Lung Metastases Simultaneously". Treatment of larger tumor volumes or ≥ 2 lung metastases simultaneously in lung cancer patient using Stereotactic Body Radiation Therapy (SBRT) in a mean-lung dose escalation study.
What is the current status of trial NCT01543672?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 62 participants. The study started on 2011-11-22. Estimated completion is 2017-10-31.
What conditions does trial NCT01543672 study?
This clinical trial studies the following conditions: Lung Cancer, Metastatic Lung Cancer.
What interventions are being tested in trial NCT01543672?
The interventions under investigation include: Stereotactic Body Radiotherapy (SBRT) (RADIATION).
Who is sponsoring clinical trial NCT01543672?
This trial is sponsored by The Netherlands Cancer Institute, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01543672 being conducted?
This trial has 5 study locations across Michigan, Pennsylvania, Ontario, Bavaria. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01543672's enrollment target sits among peer trials
62 239th of 409 higher than 169 of 409 other Lung Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Lung Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study Investigating BG-60366 in Adults With Epidermal Growth Factor Receptor (EGFR)-Mutant Non-Small Cell Lung Cancer
RECRUITING · Phase 1
-
KK-LC-1 TCR-T Cell Therapy for Gastric, Breast, Cervical, and Lung Cancer
RECRUITING · Phase 1
-
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
RECRUITING · Phase 1
-
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
RECRUITING · Phase 1
-
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
RECRUITING · Phase 1
-
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03231150 · 62 participants · NA
Plantar Fasciitis Randomized Clinical Control Trial
- NCT03458676 · 62 participants · NA
Radiologic Pathologic Correlation of Advanced MR Imaging to Guide the Biopsy of Cerebral Malignancies
- NCT03596086 · 62 participants · Phase 1
HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM
- NCT03603405 · 62 participants · Phase 1
HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI